Literature DB >> 17084363

Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages.

Steven J Kattman1, Tara L Huber, Gordon M Keller.   

Abstract

Cell-tracing studies in the mouse indicate that the cardiac lineage arises from a population that expresses the vascular endothelial growth factor receptor 2 (VEGFR2, Flk-1), suggesting that it may develop from a progenitor with vascular potential. Using the embryonic stem (ES) cell differentiation model, we have identified a cardiovascular progenitor based on the temporal expression of the primitive streak (PS) marker brachyury and Flk-1. Comparable progenitors could also be isolated from head-fold stage embryos. When cultured with cytokines known to function during cardiogenesis, individual cardiovascular progenitors generated colonies that displayed cardiomyocyte, endothelial, and vascular smooth muscle (VSM) potential. Isolation and characterization of this previously unidentified population suggests that the mammalian cardiovascular system develops from multipotential progenitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084363     DOI: 10.1016/j.devcel.2006.10.002

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  309 in total

1.  Molecular basis for Flk1 expression in hemato-cardiovascular progenitors in the mouse.

Authors:  Hiroyuki Ishitobi; Asami Wakamatsu; Fang Liu; Takuya Azami; Michito Hamada; Ken Matsumoto; Hiroshi Kataoka; Makoto Kobayashi; Kyunghee Choi; Shin-ichi Nishikawa; Satoru Takahashi; Masatsugu Ema
Journal:  Development       Date:  2011-11-09       Impact factor: 6.868

Review 2.  Stem cells and the vasculature.

Authors:  Victoria L Bautch
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  ER71 specifies Flk-1+ hemangiogenic mesoderm by inhibiting cardiac mesoderm and Wnt signaling.

Authors:  Fang Liu; Inyoung Kang; Changwon Park; Li-Wei Chang; Wei Wang; Dongjun Lee; Dae-Sik Lim; Daniel Vittet; Jeanne M Nerbonne; Kyunghee Choi
Journal:  Blood       Date:  2012-02-17       Impact factor: 22.113

4.  Eomesodermin induces Mesp1 expression and cardiac differentiation from embryonic stem cells in the absence of Activin.

Authors:  Jelle van den Ameele; Luca Tiberi; Antoine Bondue; Catherine Paulissen; Adèle Herpoel; Michelina Iacovino; Michael Kyba; Cédric Blanpain; Pierre Vanderhaeghen
Journal:  EMBO Rep       Date:  2012-04       Impact factor: 8.807

Review 5.  Embryonic stem cells for severe heart failure: why and how?

Authors:  Philippe Menasché
Journal:  J Cardiovasc Transl Res       Date:  2012-03-13       Impact factor: 4.132

6.  ER71 directs mesodermal fate decisions during embryogenesis.

Authors:  Tara L Rasmussen; Junghun Kweon; Mackenzie A Diekmann; Fikru Belema-Bedada; Qingfeng Song; Kathy Bowlin; Xiaozhong Shi; Anwarul Ferdous; Tongbin Li; Michael Kyba; Joseph M Metzger; Naoko Koyano-Nakagawa; Daniel J Garry
Journal:  Development       Date:  2011-11       Impact factor: 6.868

Review 7.  Optimizing cardiac repair and regeneration through activation of the endogenous cardiac stem cell compartment.

Authors:  Georgina M Ellison; Bernardo Nadal-Ginard; Daniele Torella
Journal:  J Cardiovasc Transl Res       Date:  2012-06-12       Impact factor: 4.132

8.  SDF-1-enhanced cardiogenesis requires CXCR4 induction in pluripotent stem cells.

Authors:  Anca Chiriac; Andre Terzic; Sungjo Park; Yasuhiro Ikeda; Randolph Faustino; Timothy J Nelson
Journal:  J Cardiovasc Transl Res       Date:  2010-09-15       Impact factor: 4.132

Review 9.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 10.  De novo myocardial regeneration: advances and pitfalls.

Authors:  Khawaja Husnain Haider; Stephanie Buccini; Rafeeq P H Ahmed; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2010-10-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.